Waqar Khan, MD: Coronary Heart Disease During COVID-19

Video

Unhealthy lifestyles during the pandemic may increase the risk of cardiovascular disease.

The coronavirus disease 2019 (COVID-19) pandemic has been a perfect storm of factors that could increase the risk of coronary heart disease.

Many across the globe have been forced to give up their exercise regimen at gyms or sports leagues, lapsing on their exercise programs. Also there likely has been an increase in unhealthy eating, with a likelihood of snacking throughout the day and takeout food for meals.

Add those factors to an increase in stress and there might be a lasting impact of the global cardiovascular health.

In an interview with HCPLive®, Waqar Khan, MD, MPH, Founder and President of Lone Star Heart and Vascular Center, explained what some of the treatment gaps are in coronary heart disease and how the COVID-19 pandemic may have impacted cardiovascular health.

Khan recently published a new book called Be Heart Smart featuring real-life patient stories and evidence-based data to give a snapshot on the state of coronary heart disease.

Khan said most of the treatment gaps are in diagnosis, as well as finding a way to treat heart disease without needing to perform major bypasses and surgeries. He said there has been a push for more treatments that reduce these procedures and he expects even more in the future.

Recent Videos
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Gus Alva, MD | Credit: Gus Alva, MD
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
© 2024 MJH Life Sciences

All rights reserved.